“Comparing Outcomes of Ticagrelor vs. Clopidogrel Therapy in Stable Myocardial Infarction Patients”

https://pubmed.ncbi.nlm.nih.gov/38117483

The study found that switching from ticagrelor to clopidogrel in stabilized myocardial infarction patients with high ischemic risk did not result in significantly different ischemic or bleeding outcomes compared to continuing ticagrelor-based dual antiplatelet therapy.